Neuberger Berman Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Neuberger Berman Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-15,500	Closed	-$193K	–	1697
2016 Q4	$193K	Sell	15,500 -19,000	-55%	-$229K	﹤0.01%	1537
2016 Q3	$472K	Buy	+34,500	New	+$346K	﹤0.01%	1283
2013 Q4	–	Sell	-5,438,792	Closed	-$100M	–	1690
2013 Q3	$100M	Sell	5,438,792 -82,376	-1%	-$1.6M	0.11%	282
2013 Q2	$96.6M	Buy	+5,521,168	New	+$97.9M	0.11%	265

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

Neuberger Berman Group's ARIA Position: Q1 2017 in Review

Neuberger Berman Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 15,500 shares — an estimated $193K sold.

Neuberger Berman Group first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $100M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Neuberger Berman Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Neuberger Berman Group sold 15,500 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $193K.
Neuberger Berman Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
Neuberger Berman Group's Ariad Pharmaceuticals Inc position peaked at $100M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Neuberger Berman Group's 13F filing for Q1 2017, filed 10 May 2017.